We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.62%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.1B
AUM Growth
+$989M
(+9.8%)
Cap. Flow
+$432M
Cap. Flow
% of AUM
3.9%
Top 10 Holdings %
Top 10 Hldgs %
14.96%
Holding
1,372
New
66
Increased
556
Reduced
543
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$45.7M |
| 2 |
Morgan Stanley
MS
|
+$44.1M |
| 3 |
Eli Lilly
LLY
|
+$32.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$30.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$29.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$51.6M |
| 2 |
Oracle
ORCL
|
+$40M |
| 3 |
Equity Residential
EQR
|
+$34.6M |
| 4 |
Citigroup
C
|
+$31.3M |
| 5 |
ExxonMobil
XOM
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.49% |
| 2 | Technology | 14.87% |
| 3 | Financials | 14.25% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Industrials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.72T
| $261M | 2.35% |
7,257,440
+270,864
| +4% | +$8.92M |
|
2
Johnson & Johnson
JNJ
$624B
| $211M | 1.91% |
1,696,113
-34,098
| -2% | -$4.07M |
|
|
3
Microsoft
MSFT
$2.83T
| $195M | 1.76% |
2,960,339
+712,938
| +32% | +$45.7M |
|
|
4
ExxonMobil
XOM
$650B
| $151M | 1.37% |
1,847,107
-317,455
| -15% | -$26.5M |
|
5
Amazon
AMZN
$2.51T
| $151M | 1.36% |
3,399,340
+495,440
| +17% | +$20.6M |
|
6
JPMorgan Chase
JPM
$930B
| $147M | 1.33% |
1,677,552
+107,486
| +7% | +$9.48M |
|
|
7
Meta Platforms (Facebook)
META
$1.54T
| $145M | 1.31% |
1,022,083
+225,202
| +28% | +$30.1M |
|
8
Bank of America
BAC
$430B
| $135M | 1.22% |
5,715,359
+649,434
| +13% | +$15.4M |
|
9
Merck
MRK
$322B
| $131M | 1.18% |
2,156,024
+371,817
| +21% | +$22.6M |
|
10
PepsiCo
PEP
$184B
| $130M | 1.17% |
1,161,006
-224,256
| -16% | -$24.1M |
|
|
11
Pfizer
PFE
$143B
| $117M | 1.05% |
3,590,742
-1,637,134
| -31% | -$51.6M |
|
12
Alphabet (Google) Class C
GOOG
$3.89T
| $108M | 0.97% |
2,591,760
+634,540
| +32% | +$26M |
|
|
13
Alphabet (Google) Class A
GOOGL
$3.89T
| $106M | 0.95% |
2,488,880
+608,360
| +32% | +$25.6M |
|
14
GE Aerospace
GE
$362B
| $102M | 0.92% |
712,104
-46,590
| -6% | -$6.74M |
|
15
Gilead Sciences
GILD
$162B
| $87.8M | 0.79% |
1,292,881
+162,841
| +14% | +$11.5M |
|
16
Medtronic
MDT
$105B
| $87.4M | 0.79% |
1,085,269
+106,706
| +11% | +$8.34M |
|
17
Chevron
CVX
$387B
| $82.6M | 0.75% |
769,205
+102,961
| +15% | +$11.5M |
|
18
Alibaba
BABA
$273B
| $78.4M | 0.71% |
727,024
+95,724
| +15% | +$9.74M |
|
|
CELG
19
DELISTED
Celgene Corp
CELG
| $78M | 0.7% |
627,150
+72,409
| +13% | +$8.67M |
|
|
AGN
20
DELISTED
Allergan plc
AGN
| $73.2M | 0.66% |
306,316
+35,000
| +13% | +$8.15M |
|
21
Abbott
ABT
$175B
| $71.3M | 0.64% |
1,604,658
+146,063
| +10% | +$6.31M |
|
22
Home Depot
HD
$324B
| $69.8M | 0.63% |
475,503
+13,414
| +3% | +$1.9M |
|
23
Booking.com
BKNG
$134B
| $69.5M | 0.63% |
975,650
-17,775
| -2% | -$1.17M |
|
24
Comcast
CMCSA
$78.3B
| $69.1M | 0.62% |
1,837,632
+3,896
| +0.2% | +$145K |
|
25
CVS Health
CVS
$136B
| $68.7M | 0.62% |
875,423
+290,969
| +50% | +$23.2M |
|
Similar funds
HF
KBC Group's Q1 2017 Portfolio in Review
As of Q1 2017, KBC Group held 1,372 positions worth $11.1B, up 9.8% from $10.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
KBC Group deployed $432M of net new capital in Q1 2017, opening 66 new positions and adding to 556 existing holdings. Its largest new stake was LogMein, Inc.: 156,863 shares worth $15.3M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $51.6M trimmed.
- KBC Group's largest Q1 2017 buy was LogMein, Inc.: 156,863 shares worth $15.3M.
- KBC Group added most to Microsoft in Q1 2017, an estimated $45.7M increase.
- KBC Group's biggest Q1 2017 reduction was Pfizer, cutting an estimated $51.6M.
- KBC Group fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $16.2M.
- KBC Group's ten largest holdings make up 15% of its $11.1B portfolio in Q1 2017.
- KBC Group opened 66 new positions and closed 69 in Q1 2017.
- KBC Group's portfolio value rose 9.8% quarter-over-quarter to $11.1B.
Based on KBC Group's 13F filing for Q1 2017, filed 10 May 2017.